Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference21 articles.
1. Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials;Roberts;JAMA,2004
2. Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy;Italiano;Ann Oncol,2008
3. Risks and benefits of phase 1 oncology trials, 1991 through 2002;Horstmann;N Engl J Med,2005
4. Clinical benefit in phase-I trials of novel molecularly targeted agents: does dose matter?;Postel-Vinay;Br J Cancer,2009
5. Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse;Jain;Clin Cancer Res,2010
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Project Optimus, an FDA initiative: Considerations for cancer drug development internationally, from an academic perspective;Frontiers in Oncology;2023-03-03
2. The ethics of “net-risk” pediatric research: views of institutional review board members and the US public;International Journal of Pediatrics and Adolescent Medicine;2023-03
3. WITHDRAWN: The ethics of “net-risk” pediatric research:Views of IRB members and the US public;International Journal of Pediatrics and Adolescent Medicine;2023-02
4. Views of IRB members regarding phase 1 pediatric oncology trials;Pediatric Hematology and Oncology;2022-05-03
5. Acceptable Risks in Pediatric Research: Views of the US Public;Pediatrics;2021-12-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3